|
2024
|
Invention
|
Phage therapy of e coli infections.
The present invention relates to bacteriophage therapy. More... |
|
2023
|
Invention
|
Phage therapy.
The present invention relates to bacteriophage therapy. More particularly, the pr... |
|
2022
|
Invention
|
Asparaginase encapsulated in red blood cells for the treatment of pancreatic cancer. The present ... |
|
|
Invention
|
Arginine deiminase encapsulated inside erythrocytes and their use in treating cancer and arginase... |
|
2021
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of diseases in the field of hematolo... |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention
of diseases in the field of hematol... |
|
|
Invention
|
Method of treating a mammal, including human, against cancer using methionine and asparagine depl... |
|
|
Invention
|
Red cell extracellular vesicles (rcevs) containing cargoes and methods of use and production ther... |
|
|
Invention
|
Phage therapy. Pseudomonas aeruginosa strains, their manufacture, components thereof, composition... |
|
2020
|
Invention
|
E coli infections. Escherichia coli strains, their manufacture, components thereof, compositions ... |
|
|
Invention
|
Pharmaceutical composition comprising erythrocytes encapsulating a plp-dependent enzyme and, a no... |
|
2019
|
Invention
|
Synergistic combinations of methionine depletion agents and immune checkpoint modulators.
The in... |
|
|
Invention
|
Synergistic combinations of methionine depletion agents and immune checkpoint modulators. The inv... |
|
2018
|
Invention
|
Pseudomonas infections. Pseudomonas aeruginosa strains, their manufacture, components thereof, co... |
|
|
Invention
|
Pharmaceutical kit comprising erythrocytes encapsulating a plp-dependent enzyme and, a non-phosph... |
|
|
Invention
|
Composition and therapeutic anti-tumour vaccine. The invention relates to a composition which ind... |
|
|
Invention
|
Anti-bacterial compositions and uses thereof. Staphylococcus aureus strains, their manufacture, c... |
|
|
Invention
|
Phage therapy. The present invention relates to bacteriophage therapy. More particularly, the pre... |
|
2016
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of cancer, blood diseases and disord... |
|
|
G/S
|
Pharmaceutical and veterinary products; chemical
preparations for medical or pharmaceutical use.... |
|
2015
|
Invention
|
Pseudomonas aeruginosa bacteriophage therapy. The present invention relates to bacteriophage ther... |
|
|
Invention
|
Erythrocytes containing arginine deiminase. Use of erythrocytes containing arginine deirainase fo... |
|
|
Invention
|
Method of treatment using a pharmaceutical composition comprising erythrocytes encapsulating a pl... |
|
|
Invention
|
Pharmaceutical composition comprising erythrocytes encapsulating a plp-dependent enzyme and its c... |
|
|
Invention
|
Phage therapy of e coli infections. The present invention relates to bacteriophage therapy. More ... |
|
|
Invention
|
Phage therapy of e coli infections. The present invention relatesto bacteriophage therapy. More p... |
|
2014
|
Invention
|
Phage therapy of pseudomonas infections. Pseudomonas aeruginosa strains, their manufacture, compo... |
|
|
Invention
|
Phage therapy of pseudomonas infections. The present invention relates to bacteriophage therapy. ... |
|
|
Invention
|
Test for predicting neutralization of asparaginase activity. Method of in vitro measurement of th... |
|
|
Invention
|
Formulation and method for the prevention and treatment of bone metastases or other bone diseases... |
|
|
Invention
|
Composition of erythrocytes encapsulating phenylalanine hydroxylase and therapeutic use thereof. ... |
|
|
Invention
|
Method for stabilising suspensions of red blood cells encapsulating an active ingredient. A metho... |
|
|
Invention
|
Method for stabilising suspensions of red blood cells encapsulating an active ingredient, the sus... |
|
2013
|
Invention
|
Lysis/resealing process and device for incorporating an active ingredient, in particular asparagi... |
|
|
Invention
|
Medicament for the treatment of acute myeloid leukemia (aml).
The present invention relates to t... |
|
|
Invention
|
Medicament for the treatment of acute myeloid leukemia (aml). The present invention relates to th... |
|
2010
|
Invention
|
Composition to induce specific immune tolerance.
The invention relates to a composition which in... |
|
2009
|
G/S
|
Pharmaceutical preparations for the prevention and the treatment of diseases in the field of hema... |
|
2008
|
G/S
|
Pharmaceutical and veterinary preparations; chemical
preparations for medical or pharmaceutical ... |
